TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07311564: A Study of LAD603 in Adults With Alopecia Areata

Sponsor: Almirall, S.A. · Phase: PHASE2 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 136 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$8,256,000

Rescue Site Savings

+$5,443,800

Unlock Full NCT07311564 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07311564 Rescue Dossier →